Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Gulf Coast Pain Institute Gets Restructured

The transaction builds upon BGL’s market leadership position in advising physician practices and related ancillary services. GCPI represents the third transaction for BGL’s Healthcare & Life Sciences investment banking practice in the pain management specialty in less than two years. Founded in 2013, Gulf Coast Pain Institute is the leading interventional pain management practice in…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

The transaction builds upon BGL’s market leadership position in advising physician practices and related ancillary services. GCPI represents the third transaction for BGL’s Healthcare & Life Sciences investment banking practice in the pain management specialty in less than two years.

Founded in 2013, Gulf Coast Pain Institute is the leading interventional pain management practice in northwest Florida. Gulf Coast Pain Institute provides a comprehensive suite of pain management and ancillary services including interventional and non-interventional procedures, physical therapy, chiropractic services, laboratory testing, durable medical equipment distribution, and pharmacy services.

Gulf Coast Pain Institute’s provider staff includes seven pain management physicians, two chiropractic physicians, two physical therapists, three physician assistants, and five advanced registered nurse practitioners throughout its 11 locations.

Read the full article here

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

In the first half of 2026, digital health AI investments reached $7.4 billion as organizations like CMS, hospitals, and startups increased their adoption of AI. Significant moves include the establishment of a new CMS technology office and a $1.7 billion acquisition in cancer technology. These developments mark an enterprise-level commitment to advancing AI in healthcare.

  • 01Digital health AI investments reached $7.4 billion in H1 2026.
  • 02The CMS established a new technology office to advance healthcare AI.
  • 03A major acquisition in cancer technology totaled $1.7 billion.

Jul 30, 2026

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

The global structural health monitoring (SHM) market is projected to surpass $8.6 billion by 2035. This growth is fueled by the integration of AI analytics, wireless sensor technologies, and the necessity to address aging infrastructure. The expansion reflects a widespread adoption of these technologies in various sectors.

  • 01The SHM market is expected to exceed $8.6 billion by 2035.
  • 02Advancements in AI-powered analytics and wireless sensors are key drivers of market growth.
  • 03Aging infrastructure is creating a demand for enhanced structural health monitoring solutions.

Jul 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512